SIGLEC15 Antikörper (AA 22-319)
Kurzübersicht für SIGLEC15 Antikörper (AA 22-319) (ABIN7825817)
Target
Alle SIGLEC15 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 22-319
-
Verwendungszweck
- Anti-SIGLEC15 Antibody
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins
-
Produktmerkmale
- Anti-SIGLEC15 Antibody (ABIN7825817). Tested in WB, ICC, IF, Flow Cytometry, ELISA applications. This antibody reacts with Human. This is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human SIGLEC15 recombinant protein (Position: R22-R319).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Western blot, 0.25-0.5 μg/mL, Human
Immunocytochemistry/Immunofluorescence, 5 μg/mL, Human
Flow Cytometry (Fixed), 1-3 μg/1x106 cells, Human
ELISA, 0.1-0.5 μg/mL
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Konzentration
- 500 μg/mL
-
Buffer
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.
-
-
- SIGLEC15 (Sialic Acid Binding Ig-Like Lectin 15 (SIGLEC15))
-
Andere Bezeichnung
- SIGLEC15
-
Hintergrund
- Predicted to be involved in regulation of actin cytoskeleton organization, regulation of bone resorption, and regulation of osteoclast development. Predicted to be located in membrane. Predicted to be part of protein-containing complex. Predicted to be active in plasma membrane.
-
Molekulargewicht
- 40 kDa
-
Gen-ID
- 284266
Target
-